The need for and creation of a comprehensive pediatric research network

Pediatric Drugs

Volumn 10, Issue 5, 2008, Pages 279-280

  Yoon, Esther Y ^a   Freed, Gary L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Children; Research drug

Indexed keywords

CHILD CARE; CLINICAL PRACTICE; CLINICAL RESEARCH; DRUG LABELING; DRUG RESEARCH; MEDICAL INFORMATICS; NOTE; PEDIATRICS; PRESCRIPTION; PRIORITY JOURNAL;

CHILD; CLINICAL TRIALS AS TOPIC; DRUG THERAPY; EUROPEAN UNION; HUMANS; INTERNATIONAL COOPERATION; ORGANIZATIONAL OBJECTIVES; PEDIATRICS; RESEARCH; UNITED STATES;

EID: 50649109223     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/00148581-200810050-00002     Document Type: Note

References (10)

1. Blumer JL. Off-label uses of drugs in children. Pediatrics 1999 Sep; 104 (3 Pt 2): 598-602
2. Cote CJ, Kauffman RE, Troendle GJ, et al. Is the "therapeutic orphan" about to be adopted? Pediatrics 1996 Jul; 98 (1): 118-23
3. US Food and Drug Administration. What we have learned from the study of drugs under the pediatric initiatives [online]. Available from URL: http://www.fda.gov/oc/opt/presentations/whatwelearned.html [Accessed 2007 Dec 20]
4. Steinbrook R. Testing medications in children. N Engl J Med 2002 Oct 31; 347 (18): 1462-70
5. Flynn JT. Successes and shortcomings of the Food and Drug Modernization Act. Am J Hypertens 2003 Oct; 16 (10): 889-91
6. Roberts R, Rodriguez W, Murphy D, et al. Pediatric drug labeling: improving the safety and efficacy of pediatric therapies. JAMA 2003 Aug 20; 290 (7): 905-11
7. Frequently asked questions on pediatric exclusivity (505A): the pediatric 'rule' and their interaction [online]. Available from URL: http://www.fda.gov/ cder/pedi- atrics/faqs.htm [Accessed 2005 Sep 12]
8. The Best Pharmaceuticals for Children Act [online]. Available from URL: http://www.fda.gov/opacom/laws/pharmkids/contents.html [Accessed 2005 Dec 1]
9. The Pediatric Research Equity Act [online]. Available from URL: http://www.fda.gov/cder/pediatric/S-650-PREA.pdf [Accessed 2005 Dec 1]
10. Approved active moieties to which FDA has issued a written request for pediatric studies under section 505A of the Federal Food, Drug, and Cosmetic Act [online]. Available from URL: http://www.fda.gov/cder/pediatric/wrlist. htm. [Accessed 2005 Sep 23]